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ABSTRACT Respiratory deficits are common following curative intent lung cancer surgery and may
reduce the patient’s ability to be physically active. We evaluated the influence of surgery on pulmonary
function, respiratory muscle strength and physical performance after lung resection.
Pulmonary function, respiratory muscle strength (maximal inspiratory/expiratory pressure) and 6-min
walk test (6MWT) were assessed pre-operatively, 2 weeks post-operatively and 6 months post-operatively
in 80 patients (age 68±9 years).
Video-assisted thoracoscopic surgery was performed in 58% of cases. Two weeks post-operatively, we
found a significant decline in pulmonary function (forced vital capacity −0.6±0.6 L and forced expiratory
volume in 1 s −0.43±0.4 L; both p<0.0001), 6MWT (−37.6±74.8 m; p<0.0001) and oxygenation
(−2.9±4.7 units; p<0.001), while maximal inspiratory and maximal expiratory pressure were unaffected. At
6 months post-operatively, pulmonary function and oxygenation remained significantly decreased
(p<0.001), whereas 6MWT was recovered.
We conclude that lung resection has a significant short- and long-term impact on pulmonary function
and oxygenation, but not on respiratory muscle strength. Future research should focus on mechanisms
negatively influencing post-operative pulmonary function other than impaired respiratory muscle strength.
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LUNG CANCER
Introduction
Lung resection remains the main curative treatment for early-stage lung cancer. However, surgery results
in persistent reduction in post-operative pulmonary function of 10–40% [1, 2], which may contribute to
functional impairments [3]. The cause of impaired pulmonary function following lung resection is
multifactorial, including the removal of lung tissue and alterations in chest wall mechanics due to the
surgical incision [4]. A significant decrease in respiratory muscle strength (RMS) 4 and 12 weeks after
thoracotomy has been reported [5–7], while another study describes spontaneous recovery 30 days
post-operatively [8]. There is inconsistency in the literature regarding the influence of the surgical
approach on RMS. Video-assisted thoracoscopic surgery (VATS) may induce a smaller decrease in RMS
compared with thoracotomy [9–11].
After major lung resection, a decline in ambulatory daily activity has been reported, despite recovery of the
functional exercise capacity 1 month post-operatively [12, 13]. Whereas respiratory muscle dysfunction
following surgery has been suggested to negatively influence post-operative pulmonary function [14], the
influence of respiratory muscle dysfunction on functional outcomes has not been subject to studies. Thus,
the aim of this study was to describe pulmonary function, RMS and physical performance within a period
of up to 6 months after surgery.
Materials and methods
Subjects and design
Eligible were patients aged ⩾18 years, scheduled for lung resection on the suspicion of or confirmed lung
cancer at the Dept of Cardiothoracic Surgery, Aalborg University Hospital, Denmark, between November
2012 and April 2014. Approximately 100 surgeries for confirmed lung cancer are performed in this centre
annually. The exclusion criteria were physical or mental deficits adversely influencing walking ability,
inability to understand written and spoken Danish, previous ipsilateral lung resection, disseminated or
nonresectable lung cancer, pancoast tumour, and thoracic or abdominal surgery within 1 year
pre-operatively. The extent of expected or resected lung tissue is not routinely calculated in all patients.
The majority of patients (n=59) participated in a randomised controlled trial designed to evaluate the
effects of post-operative inspiratory muscle training on RMS [15]. The study was approved by the Research
Ethics Committee (N-20120027) and the Danish Data Protection Agency (N-2008-58-0028). Written
informed consent was obtained prior to inclusion.
Perioperative management
All patients received pre-medication and general anaesthesia (propofol/remifentanil). Lung resections were
performed either by conventional three-port VATS or by muscle-sparing lateral or postero-lateral
thoracotomy (preserving the musculus latissimus dorsi and musculus serratus anterior). The choice of the
surgical approach and the use of a rib retractor were at the discretion of the surgeon. In general,
thoracotomy is used for major resections, while VATS is used for minor resections or resection in patients
with compromised lung function. At the end of the surgery a single chest tube connected to a suction
system with negative pressure of 5–10 cmH2O (Thopaz Chest Drainage System; Medela, Baar, Switzerland)
was placed in the pleural space. No drainage was used after pneumonectomy. Pain management was
primarily achieved by continuous epidural infusion over a period of 1–5 days, supplemented with per os
nonsteroidal anti-inflammatory drugs and paracetamol. All patients received post-operative respiratory
physiotherapy consisting of breathing exercises and instructions in coughing and huffing and early
mobilisation [15].
Outcome measurements
The assessments were performed pre-operatively, 2 weeks post-operatively and 6 months post-operatively.
Assessment of RMS measured at the mouth was performed according to American Thoracic Society/
European Respiratory Society guidelines [16]. We used a hand-held electronic pressure transducer (Micro
RPM; MicroMedical/CareFusion, Chatham, UK) with a flanged mouthpiece and the patient sitting in a
chair. Measurements were performed from total lung capacity for maximal expiratory pressure (MEP) and
from residual volume for maximal inspiratory pressure (MIP). The highest plateau pressure (1-s average)
obtained after at least five attempts, with three attempts lying within 10 cmH2O of each other, was used.
The percentage of predicted normal values was also calculated [17]. Patients rated their wound pain
during the assessment of RMS on a 0–10 numerical rating scale. Higher ratings corresponded to higher
levels of pain.
Forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) were measured using a calibrated
portable spirometer (Spirovit SP-2; Schiller, Baar, Switzerland). The best of three measurements was
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recorded [18] and the FEV1/FVC ratio was calculated. Predicted values were related to age, sex and height
[19].
The 6-min walk test (6MWT) was used to assess physical performance. The test was performed twice,
according to American Thoracic Society guidelines [20], in a 20-m corridor. Results were related to
reference values [21]. Peripheral oxygen saturation measured by pulse oximetry (SpO2) (ri-fox N; Riester,
Jungingen, Germany) and patient’s experienced dyspnoea (Borg CR10 scale) [22] were assessed before and
after the test. The perceived exertion post-6MWT was assessed using a modified 0–10 Borg scale. Higher
ratings corresponded to higher levels of dyspnoea or exertion.
Statistical analysis
Data were reported as mean±standard deviation and median (minimum–maximum range) for ordinal or
continuous variables, and as number and percentages for categorical variables. Nonparametric tests were
used for analysis: the Wilcoxon signed-rank test for within-groups comparisons, the Mann–Whitney
U-test for between-groups comparisons and the Kruskal–Wallis test for comparisons in categorical
variables. For calculation of relative changes we used: (value at 2 weeks−value at baseline)/value at
baseline) and likewise for values at the 6-month follow-up. All statistical tests were performed two-sided
and conducted at the 5% significance level with SAS version 9 (SAS Institute, Cary, NC, USA).
Results
The study flowchart is provided as supplementary figure S1. 121 out of 232 screened patients were eligible,
88 were recruited and 80 completed the assessments 2 weeks post-operatively. 65 patients completed the
assessments 6 months post-operatively. Demographic and post-operative data for the study sample are
summarised in tables 1 and 2, which also present characteristics of the participants who completed all
assessments and those not available after 6 months. At baseline, as a group, participants did not present
impairments in RMS or 6MWT (both >100%). Chronic obstructive pulmonary disease (COPD) was
diagnosed in 36% of cases. All patients underwent lung resection and radical surgery was performed in
case of a malignant diagnosis. Two patients died between 2 and 6 months post-operatively.
Nonmalignancy was the main reason for dropouts (n=7) 6 months post-operatively (no need for medical
follow-up, according to hospital routines).
At 2 weeks post-operatively, RMS remained unchanged. Reductions in 6MWT (mean −37.6±74.8 m;
p<0.001), SpO2 post-6MWT (−2.9±4.7 units; p<0.0001) (table 3), and FVC and FEV1 (both p<0.001) were
detected (table 4). We also found that dyspnoea and exertion post-6MWT were significantly increased
TABLE 1 Demographics and patient characteristics stratified by compliance to the 6-month
follow-up protocol
Baseline Completed 6-month follow-up Dropout at 6 months
Patients 80 65 15
Age years 68±9
69 (46–82)
68±9
67 (51–82)
68±11
0 (46–81)
Males 46 (58) 39 (60) 7 (47)
COPD#
Mild: FEV1 ⩾80% pred 8 (10) 8 (12) 0
Moderate: FEV1 50–80% pred 15 (15) 9 (14) 6 (8)
Severe: FEV1 30–50% pred 6 (8) 6 (9) 0
Previous cancer diagnosis 31 (40) 24 (37) 7 (44)
Pack-years¶ 35 (30) 33 (28) 47 (36)
DLCO % pred 67 (17) 67 (16) 67 (17)
ASA physical status
2 64 (80) 52 (80) 12 (80)
3 16 (20) 13 (20) 3 (20)
ECOG performance status
0 51 (64) 44 (68) 7 (47)
1 29 (36) 21 (33) 8 (53)
Values are presented as n, mean±SD, median (minimum–maximum range) or n (%). COPD: chronic
obstructive pulmonary disease; FEV1: forced expiratory volume in 1 s; DLCO: diffusing capacity of the lung
for carbon monoxide; ASA: American Society of Anaesthesiologists; ECOG: Eastern Cooperative Oncology
Group. #: n=29; ¶: n=72.
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(both p<0.0001). The relative changes in pulmonary function, 6MWT and SpO2 for wedge resection/
segmentectomy, lobectomy, bilobectomy and pneumonectomy were, respectively: FVC −14±10%,
−16±15%, −27±5% and −47±5% (p=0.000); FEV1 −13±13%, −19±13%, −29±5% and −47±5% (p=0.000);
6MWT −2±11%, −0.8±14%, −25±8% and −16±14% (p=0.005); SpO2 −1±4%, −5±6%, −2±1% and −4±7%
(p=0.123). The relative change in RMS was similar across the different resection degrees (MIP: p=0.499;
MEP: p=0.134) (not illustrated).
At 6 months, MEP remained unchanged while MIP was significantly improved compared with baseline
values (6.2±16 cmH2O; p=0.0009); 6MWT improved from 2 weeks post-operatively and was comparable to
pre-operative values. SpO2, dyspnoea and exertion post-6MWT remained significantly lower compared with
pre-operative values (table 3). In addition, pulmonary function remained significantly decreased (FVC:
p<0.0001; FEV1: p<0.001) (table 4). The relative changes in pulmonary function, 6MWT and SpO2 for
wedge resection/segmentectomy, lobectomy, bilobectomy and pneumonectomy were, respectively: FVC
−7±11%, −4±13%, −15±15% and −35±5% (p=0.001); FEV1 −7±7%, −8±10%, −20±14% and −32±8%
(p=0.001); 6MWT −7±3%, −1±11%, −13±14% and −16±12% (p=0.251); SpO2 −1±4%, −2±4%, −3±2%
and −2±6% (p=0.919). The relative change in RMS was similar across the different resection degrees
(MIP: p=0.797; MEP: p=0.327) (not illustrated).
Individual characteristics of subjects with SpO2 ⩽90% at 2 weeks post-operatively are shown in
supplementary table S1. Supplementary table S2 shows outcome measures 2 weeks post-operatively for the
whole sample and stratified by desaturators and nondesaturators.
Discussion
This study was aimed at describing pulmonary function, RMS and physical performance within a period
of up to 6 months after curative intent lung cancer surgery. We found that 1) both pulmonary function
and physical performance decreased significantly 2 weeks post-operatively, 2) SpO2 after the 6MWT was
significantly decreased at 2 weeks and 6 months post-operatively, and 3) RMS was not affected 2 weeks
post-operatively. Thus, the post-operative decrease in oxygenation post-6MWT is not likely related to
impaired RMS, since the latter was already recovered 2 weeks after the surgery.
TABLE 2 Surgical and cancer characteristics of the study population stratified by compliance
to the 6-month follow-up protocol
Baseline Completed 6-month
follow-up
Dropout at
6 months
Patients 80 65 15
VATS 46 (58) 34 (52) 12 (80)
Resection degree
Wedge resection/segmentectomy 26 (33) 17 (26) 9 (60)
Lobectomy 45 (56) 39 (60) 6 (33)
Bilobectomy 3 (4) 3 (5) 0
Pneumonectomy 6 (7) 6 (9) 0
Duration of surgery min 132±60
120 (30–320)
136±58
120 (45–320)
99±47
95 (30–150)
Duration of chest tubes h 68±77
29 (8–360)
74±83
33 (8–360)
44±48
24 (11–172)
Length of hospital stay# days 8±5
6 (3–30)
8±5
6 (3–25)
7±7
5 (3–30)
Post-operative chemotherapy 20 (25) 19 (29) 1 (7)
Cancer characteristics
NSCLC 54 (67) 47 (72) 7 (47)
Stage IA/IB¶ 13/18 (24/34) 11/15 (23.5/32) 2/3 (28.5/43)
Stage IIA/IIB¶ 1/11 (2/20) 1/9 (2/19) 0/2 (0/28.5)
Stage IIIA¶ 11 (20) 11 (23.5) 0
Metastatic tumour 11 (14) 10 (16) 1 (6)
Nonmalignancy 15 (19) 8 (12) 7 (47)
Values are presented as n, n (%), mean±SD or median (minimum–maximum range). VATS: video-assisted
thoracoscopic surgery; NSCLC: nonsmall cell lung cancer. #: length of hospital stay includes transfer to
other units; ¶: data refer only to NSCLC.
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Our data show a significant decline in SpO2 post-6MWT: from 95% to 92% 2 weeks post-operatively and to
93% after 6 months. At the same time, patients experienced greater dyspnoea and exertion after the
6MWT (∼1 unit) at both follow-ups, despite recovery of walked distance by 6 months post-operatively.
Similar findings of decreased oxygenation following the 6MWT have been described 2 [23] and 6–10
TABLE 3 Respiratory muscle strength and physical performance: changes from baseline to 2 weeks and 6 months after
surgery
Baseline 2 weeks Change 6 months Change
Baseline to
2 weeks
p-value Baseline to
6 months
p-value
Patients 80 80 65
MIP cmH2O 85±30
86 (23–152)
84±32
78 (18–181)
−0.8±18.1
1.5 (−44–60)
1.00 94±31
94 (19–183)
6.2±16
5.0 (−57–40)
0.0009
MIP % pred 104±30
106 (40–165)
101±34
100 (30–184)
−6.6±20
−6.0 (−49–61)
0.43 114±31
117 (32–196)
9.2±22
6.0 (−59–68)
0.011
MEP cmH2O 102±33
101 (37–185)
99±34
96 (36–203)
−3.3±18.4
0.00 (−95–44)
0.23 108±37
108 (37–247)
3.1±17.8
4.0 (−36–62)
0.14
MEP % pred 106±25
103 (49–168)
102±28
102 (41–171)
−3.2±20.5
−3 (−61–50)
0.52 110±30
103 (46–207)
4.2±18
4.6 (−38–54)
0.14
6MWT m#,¶ 506±125
519 (120–751)
467±135
472 (119–726)
−137.6±74.8
−28 (−304–116)
<0.0001 519±127
527 (231–793)
−5.6±60.1
−3.0 (−132–224)
0.52
6MWT % pred 100±20
102 (32–136)
92±22
94 (24–148)
−7.4±14.9
−5.0 (−61–23)
<0.0001 101±20
104 (52–146)
−1.6±12.5
0.0 (−33–38)
0.32
Oxygen saturation
at rest, before
6MWT %#,¶
96±1.9
97 (87–99)
96±1.6
97 (91–98)
0.1±1.5
0.0 (−3.0–6.0)
0.57 97±1.2
97 (93–99)
0.4±1.8
0.0 (−2–9.0)
0.21
Oxygen saturation
post-6MWT %#,¶
95±3.7
96 (80–100)
92±5
93 (77–98)
−2.9±4.7
−2 (−19–8)
<0.0001 93±3.9
94 (80–98)
−2.1±3.7
−2 (−12–7)
<0.0001
Dyspnoea
units#,¶,+
2±1.5
2 (0–7)
3±1.9
3 (−0.8–8.5)
1.1±1.7
1 (−3–6)
<0.0001 3±1.8
3 (−1–7)
0.8±1.5
0.5 (−2–5)
0.0001
Exertion units 3.2±2.1
3 (0–10)
4.3±1.9
4 (1–9)
1.1±1.9
1 (−6–5)
<0.0001 3.92±2.2
3 (0–10)
0.86±2
1 (−5–6)
0.0014
Data are presented as n, mean±SD or median (minimum–maximum range), unless otherwise stated. MIP: maximal inspiratory pressure; MEP:
maximal expiratory pressure; 6MWT: 6-minute walk test. #: n=79 at 2 weeks; ¶: n=61 at 6 months; +: difference after–before the 6MWT.
Statistical analysis by Wilcoxon signed-rank test.
TABLE 4 Lung volumes: changes from baseline to 2 weeks and 6 months after surgery
Baseline 2 weeks Change 6 months Change
Baseline to 2 weeks p-value Baseline to 6 months p-value
Patients 80 80 65
FVC L 3.4±0.9
3.4 (1.5–5.6)
2.8±0.9
2.8 (1–5)
−0.6±0.6
−0.6 (−2.5–0.7)
<0.0001 3.2±0.1
3.1 (1.3–5.7)
−0.29±0.5
−0.29 (−1.7–0.8)
<0.0001
FVC % pred 101±21
98 (59–170)
83±21
83 (35–131)
−17.6±17.6
−16 (−7.6–17)
<0.0001 94±21.9
91 (56–150)
−8.9±17.7
−7 (−6.6–30)
<0.0001
FEV1 L 2.3±0.8
2.2 (0.7–4.2)
1.8±0.7
1.8 (0.6–3.6)
−0.43±0. 4
−0.43 (−1.6–0.3)
<0.0001 2.1±0.7
2.1 (0.8–4)
−0.27±0.3
−0.2 (−0.9–0.5)
<0.001
FEV1 % pred 83±21.4
86 (28–134)
68±20.3
66 (20–118)
−15.2±14.1
−16 (−55–16)
<0.0001 76±18.5
75 (28–120)
−9.6±11.4
−9 (−42–19)
<0.0001
FEV1/FVC 66±12.9
68.4 (21.6–85)
65±12.5
65.5 (39–88.6)
−0.92±7.69
12 (−18.6–20.5)
0.17 65±11.5
65.1 (32.5–87.6)
−2.12±7.12
−2.5 (−16.7–17.9)
0.002
FEV1/FVC % pred 87±17.3
91 (29–111)
86±16
87 (52–119)
−0.9±1
−0.1 (−25–29)
0.28 86±15
87 (43–114)
−2±1
−3 (−21–24)
0.017
Data are presented as n, mean±SD or median (minimum–maximum range), unless otherwise stated. FVC: forced vital capacity; FEV1: forced
expiratory volume in 1 s. Statistical analysis by Wilcoxon signed-rank test.
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weeks [24] following lobectomy. Our data indicate that impaired oxygenation after the 6MWT is present
not only after lobectomy and major resections, but also following minor resections. The impaired
oxygenation may be explained by a degree of ventilatory inefficiency on a given workload, i.e. a
combination of ventilatory and gas exchange impairments, secondary to the removal of lung tissue [14],
which might result in a persistent mismatch in the oxygen delivery capacity during exercise. Patients with
SpO2 ⩽90% 2 weeks post-operatively had lower pre-operative values of diffusing capacity of the lung for
carbon monoxide (DLCO) when compared with nondesaturators, despite a relatively more preserved
post-operative FEV1. CAVALHERI et al. [24] also suggested that the increased sensation of dyspnoea after
lung resections might be related to the development of lung hyperinflation during exercise, similar to
those with COPD [25]. Monitoring tidal volumes during the 6MWT and changes in inspiratory capacity
before and after the 6MWT, in particular in patients with impaired DLCO, could provide important
information regarding the mechanisms involved in the ventilatory limitations during exercise in this
population.
Our findings that RMS was not reduced 2 weeks after lung resection are contradictory to previous studies,
as impairments in both inspiratory and expiratory muscle strength have been reported after major [5–8,
10] and minor [11] lung resections, evaluated at different time-points: 1 [9, 11], 4 [11] and 12 weeks
post-operatively [5–7]. A single study performed by BORGES-SANTOS et al. [8] reported on normalisation of
MIP and MEP between days 10 and 15 following thoracotomy. A smaller decrease in RMS has been
reported following VATS compared with non-muscle-sparing thoracotomy [6, 9, 10]. The surgeons in our
institution perform thoracotomy with muscle-sparing techniques for major resections, while VATS is
mostly used in patients with limited pulmonary function or for minor resections. This practice is in
accordance with other authors, who describe better outcomes following VATS compared with traditional
open techniques [26]. As a result of the reduced damage to the chest wall, less invasive techniques may
ameliorate the negative impact of the surgery on pulmonary function and reduce the risk of post-operative
pulmonary complications [5, 14].
Two major issues may explain the diverging reports in the literature on the negative effect of surgery on
RMS and support our findings of no reduction in RMS 2 weeks after surgery. First, comparisons with
older studies can be difficult, because there have been major changes over the last decade in the clinical
pathway following lung resection. Factors such as the increasing use of VATS, improvements in pain
management and the incorporation of structured early mobilisation may enhance the overall recovery [27],
including the recovery of RMS. Second, because measurement of RMS is effort dependent [17], impaired
RMS, especially early after the surgery, may reflect higher levels of pain in the surgical site, in particular
following standard thoracotomy [28], which could explain the decrease in RMS reported in some studies
[5, 6, 9]. Our data do not support that pain has an impact in the assessment of RMS, considering that the
mean pain rating 2 weeks post-operatively was low (score of 1 on the numerical rating scale).
In a previous study from our group we evaluated the effects of 2 weeks of post-operative inspiratory
muscle training on RMS in high-risk patients following lung cancer surgery in a randomised controlled
setting [15]. We reported on a significant decrease in RMS by post-operative day 5 with recovery 2 weeks
post-operatively. The study included 73% of the present study’s cohort, of which 33 patients received the
active intervention. Considering that we found no differences between the groups in RMS at 5 days and
2 weeks post-operatively [15], we cannot endorse that inspiratory muscle training as the active intervention
could have enhanced recovery of RMS to a degree that influenced the results of the present study.
Meanwhile, as we did not assess RMS by post-operative day 5 in all patients, we cannot exclude the
presence of a transient decline in RMS early after the surgery. In the present study we report on a
significant increase in MIP of 6.2 cmH2O 6 months post-operatively. An increase in MIP of 13 cmH2O has
been reported as clinically relevant in the COPD population [29], but there is no definition of a clinically
relevant change in MIP following lung resection. Although statistically significant, we do not consider the
increase in MIP at 6 months to be of clinical relevance, considering that SpO2, dyspnoea and exertion at
this time-point were higher compared with baseline values.
Strengths and limitations
The dropout percentage in our study was 17% at the 6-month follow-up and this is consistent with
previous reporting [13, 30]. This was a single-centre study with a heterogeneous group regarding the
degree of resection of lung tissue and included patients with different diagnoses (nonsmall cell lung
cancer, metastatic tumour and nonmalignant disease). Surgeons perform segmentectomies and wedge
resections in patients with compromised cardiorespiratory function/early-stage nonsmall cell lung cancer
in order to preserve as much of the parenchyma as possible [31]. We present results on relative changes in
outcome measures 2 weeks and 6 months post-operatively stratified by the resection degree, since our
results suggest that short- and long-term desaturation post-6MWT may occur regardless of the resection
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degree. Meanwhile, due to the small sample size and subsequent large standard deviations, the stratified
results we present should not be interpreted conclusively. Also, we could not assess the influence of the
surgical approach (VATS versus thoracotomy) on RMS as a sample of 70 patients in each group would be
necessary to detect a difference in MIP of 15±32 cmH2O [32], considering 80% power and a significance
level of <0.05. Furthermore, the reliability of measurement of SpO2 can be questioned, since arterial blood
gas analysis is the gold standard in accuracy for the detection of hypoxaemia. We chose to use SpO2
because it is a noninvasive method widely used in the clinical and rehabilitation setting. Furthermore, its
accuracy is within ±2–3 units from the results obtained from the arterial blood gas analysis [33]. It also is
important to consider that the 6MWT is a submaximal test and may not induce higher levels of dyspnoea
compared with an incremental test. Meanwhile, the 6MWT has been shown to detect a greater decline in
SpO2 compared with an incremental, cycle-based test [24], supposedly related to the use of larger muscle
mass involved in walking. Finally, comparison between measurement of RMS by mouth pressure, as
performed in our study, with an effort-independent technique that measures diaphragm contractility
(twitch transdiaphragmatic pressure) [20, 34] is warranted in the surgical setting as it may provide useful
diagnostic data on respiratory muscle weakness.
Conclusions
Lung resection has a significant short- and long-term impact on pulmonary function as well as on
oxygenation levels and symptoms following the 6MWT, but not on RMS. Future research should focus on
mechanisms other than post-operative impairments in RMS, which may explain the respiratory deficits
influencing physical performance in this population.
References
1 Brunelli A, Xiume F, Refai M, et al. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance
following major lung resection: a prospective follow-up analysis. Chest 2007; 131: 141–147.
2 Cukic V. Reduction of pulmonary function after surgical lung resections of different volume. Med Arch 2014; 68:
231–235.
3 Poghosyan H, Sheldon LK, Leveille SG, et al. Health-related quality of life after surgical treatment in patients with
non-small cell lung cancer: a systematic review. Lung Cancer 2013; 81: 11–26.
4 Miserocchi G, Beretta E, Rivolta I. Respiratory mechanics and fluid dynamics after lung resection surgery. Thorac
Surg Clin 2010; 20: 345–357.
5 Nomori H, Kobayashi R, Fuyuno G, et al. Preoperative respiratory muscle training. Assessment in thoracic surgery
patients with special reference to postoperative pulmonary complications. Chest 1994; 105: 1782–1788.
6 Weiner P, Man A, Weiner M, et al. The effect of incentive spirometry and inspiratory muscle training on
pulmonary function after lung resection. J Thorac Cardiovasc Surg 1997; 113: 552–557.
7 Ziyade S, Baskent A, Tanju S, et al. Isokinetic muscle strength after thoracotomy: standard vs. muscle-sparing
posterolateral thoracotomy. Thorac Cardiovasc Surg 2010; 58: 295–298.
8 Borges-Santos E, Genz IC, Longo AF, et al. Pulmonary function, respiratory muscle strength and quality of life in
patients submitted to elective thoracotomies. Rev Col Bras Cir 2012; 39: 4–9.
9 Nomori H, Horio H, Fuyuno G, et al. Respiratory muscle strength after lung resection with special reference to
age and procedures of thoracotomy. Eur J Cardiothorac Surg 1996; 10: 352–358.
10 Nomori H, Horio H, Naruke T, et al. What is the advantage of a thoracoscopic lobectomy over a limited
thoracotomy procedure for lung cancer surgery? Ann Thorac Surg 2001; 72: 879–884.
11 Bernard A, Brondel L, Arnal E, et al. Evaluation of respiratory muscle strength by randomized controlled trial
comparing thoracoscopy, transaxillary thoracotomy, and posterolateral thoracotomy for lung biopsy. Eur J
Cardiothorac Surg 2006; 29: 596–600.
12 Novoa N, Varela G, Jimenez MF, et al. Influence of major pulmonary resection on postoperative daily ambulatory
activity of the patients. Interact Cardiovasc Thorac Surg 2009; 9: 934–938.
13 Arbane G, Douiri A, Hart N, et al. Effect of postoperative physical training on activity after curative surgery for
non-small cell lung cancer: a multicentre randomised controlled trial. Physiotherapy 2014; 100: 100–107.
14 Siafakas NM, Mitrouska I, Argiana E, et al. Effects of surgery on the function of the respiratory muscles. Monaldi
Arch Chest Dis 1999; 54: 526–531.
15 Brocki BC, Andreasen JJ, Langer D, et al. Postoperative inspiratory muscle training in addition to breathing
exercises and early mobilization improves oxygenation in high-risk patients after lung cancer surgery: a
randomized controlled trial. Eur J Cardiothorac Surg 2016; 49: 1483–1491.
16 American Thoracic Society, European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J
Respir Crit Care Med 2002; 166: 518–624.
17 Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009; 54:
1348–1359.
18 Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
19 Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party
Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the
European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5–40.
20 American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med
2002; 166: 111–117.
21 Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med
1998; 158: 1384–1387.
22 Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377–381.
https://doi.org/10.1183/23120541.00055-2017 7
LUNG CANCER | B.C. BROCKI ET AL.
23 Nomori H, Ohtsuka T, Horio H, et al. Difference in the impairment of vital capacity and 6-minute walking after a
lobectomy performed by thoracoscopic surgery, an anterior limited thoracotomy, an anteroaxillary thoracotomy,
and a posterolateral thoracotomy. Surg Today 2003; 33: 7–12.
24 Cavalheri V, Jenkins S, Cecins N, et al. Comparison of the six-minute walk test with a cycle-based
cardiopulmonary exercise test in people following curative intent treatment for non-small cell lung cancer. Chron
Respir Dis 2016; 13: 118–127.
25 Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients
with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 622–629.
26 Zhang R, Ferguson MK. Video-assisted versus open lobectomy in patients with compromised lung function: a
literature review and meta-analysis. PLoS One 2015; 10: e0124512.
27 Granger CL. Physiotherapy management of lung cancer. J Physiother 2016; 62: 60–67.
28 Demmy TL, Nwogu C. Is video-assisted thoracic surgery lobectomy better? Quality of life considerations. Ann
Thorac Surg 2008; 85: S719–S728.
29 Gosselink R, De VJ, van den Heuvel SP, et al. Impact of inspiratory muscle training in patients with COPD: what
is the evidence? Eur Respir J 2011; 37: 416–425.
30 Arbane G, Tropman D, Jackson D, et al. Evaluation of an early exercise intervention after thoracotomy for
non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised
controlled trial. Lung Cancer 2011; 71: 229–234.
31 Bedetti B, Bertolaccini L, Rocco R, et al. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a
systematic review and meta-analysis. J Thorac Dis 2017; 9: 1615–1623.
32 Mans CM, Reeve JC, Elkins MR. Postoperative outcomes following preoperative inspiratory muscle training in
patients undergoing cardiothoracic or upper abdominal surgery: a systematic review and meta analysis. Clin
Rehabil 2015; 29: 426–38.
33 Pretto JJ, Roebuck T, Beckert L, et al. Clinical use of pulse oximetry: official guidelines from the Thoracic Society
of Australia and New Zealand. Respirology 2014; 19: 38–46.
34 Steier J, Kaul S, Seymour J, et al. The value of multiple tests of respiratory muscle strength. Thorax 2007; 62:
975–980.
https://doi.org/10.1183/23120541.00055-2017 8
LUNG CANCER | B.C. BROCKI ET AL.
